LENÁRT, Sára, Peter LENÁRT, Lucia KNOPFOVÁ, Hana KOTASOVÁ, Vendula PELKOVÁ, Veronika SEDLÁKOVÁ, Ondřej VACEK, Jana POKLUDOVÁ, Vladimír ČAN, Jan ŠMARDA, Karel SOUČEK, Aleš HAMPL and Petr BENEŠ. TACSTD2 upregulation is an early reaction to lung infection. Nature Scientific Reports. London: NATURE RESEARCH, 2022, vol. 12, No 1, p. 9583-9597. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-022-13637-9.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name TACSTD2 upregulation is an early reaction to lung infection
Authors LENÁRT, Sára (203 Czech Republic, belonging to the institution), Peter LENÁRT (703 Slovakia, belonging to the institution), Lucia KNOPFOVÁ (203 Czech Republic, belonging to the institution), Hana KOTASOVÁ (203 Czech Republic, belonging to the institution), Vendula PELKOVÁ (203 Czech Republic, belonging to the institution), Veronika SEDLÁKOVÁ (203 Czech Republic, belonging to the institution), Ondřej VACEK (203 Czech Republic, belonging to the institution), Jana POKLUDOVÁ (203 Czech Republic, belonging to the institution), Vladimír ČAN (703 Slovakia), Jan ŠMARDA (203 Czech Republic, belonging to the institution), Karel SOUČEK (203 Czech Republic, belonging to the institution), Aleš HAMPL (203 Czech Republic, belonging to the institution) and Petr BENEŠ (203 Czech Republic, guarantor, belonging to the institution).
Edition Nature Scientific Reports, London, NATURE RESEARCH, 2022, 2045-2322.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10700 1.7 Other natural sciences
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.600
RIV identification code RIV/00216224:14310/22:00126036
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1038/s41598-022-13637-9
UT WoS 000809441100064
Keywords in English INNATE IMMUNE-RESPONSE; NF-KAPPA-B; EXPRESSION ATLAS; VIRAL-INFECTION; BARRIER; CELLS; GENE; IDENTIFICATION; CANCER; MURINE
Tags 14110517, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Marie Šípková, DiS., učo 437722. Changed: 3/4/2023 09:12.
Abstract
TACSTD2 encodes a transmembrane glycoprotein Trop2 commonly overexpressed in carcinomas. While the Trop2 protein was discovered already in 1981 and first antibody-drug conjugate targeting Trop2 were recently approved for cancer therapy, the physiological role of Trop2 is still not fully understood. In this article, we show that TACSTD2/Trop2 expression is evolutionarily conserved in lungs of various vertebrates. By analysis of publicly available transcriptomic data we demonstrate that TACSTD2 level consistently increases in lungs infected with miscellaneous, but mainly viral pathogens. Single cell and subpopulation based transcriptomic data revealed that the major source of TACSTD2 transcript are lung epithelial cells and their progenitors and that TACSTD2 is induced directly in lung epithelial cells following infection. Increase in TACSTD2 expression may represent a mechanism to maintain/restore epithelial barrier function and contribute to regeneration process in infected/damaged lungs.
Links
MUNI/A/1380/2021, interní kód MUName: Vytvoření 3D modelu plicní tkáně pro modelování plicních onemocnění a testování léčiv
Investor: Masaryk University
MUNI/A/1522/2020, interní kód MUName: Podpora výzkumné činnosti studentů molekulární biologie a genetiky 9 (Acronym: MBG9)
Investor: Masaryk University
MUNI/A/1689/2020, interní kód MUName: Zdroje pro tkáňové inženýrství 11 (Acronym: TissueEng 11)
Investor: Masaryk University
NV18-07-00073, research and development projectName: c-Myb a jeho transkripční program ve fyziologických a patologických osteogenních procesech
Investor: Ministry of Health of the CR
PrintDisplayed: 16/7/2024 08:04